Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free ARAY Stock Alerts

Accuray (ARAY) Financials

Accuray logo
$0.27 +0.00 (+0.30%)
As of 09/4/2026 04:00 PM Eastern
Compare
Annual Income Statements for Accuray

Annual Income Statements for Accuray

This table shows Accuray's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -26 -30 299 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59 -49
Consolidated Net Income / (Loss)		 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59 -49
Net Income / (Loss) Continuing Operations		 -26 -30 299 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59 -49
Total Pre-Tax Income 		-23 -29 -23 -14 5.69 -4.56 -2.00 -6.79 -12 1.13 -47
Total Operating Income		 -4.87 -9.82 -3.80 0.58 13 22 8.15 2.38 0.50 7.84 -26
Total Gross Profit		 159 141 323 163 150 160 160 154 143 147 111
Total Revenue		 399 383 810 419 383 396 430 448 447 459 402
Operating Revenue		 399 383 810 419 383 396 430 448 447 459 402
Total Cost of Revenue		 240 242 486 256 233 237 270 294 304 312 290
Operating Cost of Revenue		 240 242 486 256 233 237 270 294 304 312 290
Total Operating Expenses		 164 151 3.80 162 137 137 152 152 142 139 138
Selling, General & Admin Expense		 50 44 48 50 40 42 44 48 50 48 45
Marketing Expense		 57 57 60 56 47 43 50 46 43 43 39
Research & Development Expense		 57 50 57 56 50 53 58 57 50 48 38
Restructuring Charge		 - - - - - - - - - 0.00 16
Total Other Income / (Expense), net		 -18 -19 -19 -15 -6.85 -27 -10 -9.17 -12 -6.71 -21
Interest Expense		 - - - - - - 8.13 11 12 11 33
Interest & Investment Income		 - - 0.00 0.00 -0.15 0.87 0.24 2.57 1.84 4.71 1.12
Other Income / (Expense), net		 -18 -19 -19 -15 -6.70 -28 -2.26 -1.11 -2.54 0.06 11
Income Tax Expense		 2.34 1.04 0.88 2.09 1.86 1.75 3.35 2.49 3.73 2.73 1.95
Basic Earnings per Share		 ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) ($0.02) ($0.40)
Weighted Average Basic Shares Outstanding		 80.51M 82.50M 84.89M 87.47M 89.87M 92.03M 92.10M 94.88M 98.27M 102.77M 122.64M
Weighted Average Diluted Shares Outstanding		 80.51M 82.50M 84.89M 87.47M 90.62M 92.03M 92.10M 94.88M 100.27M 112.68M 119.44M
Weighted Average Basic & Diluted Shares Outstanding		 80.51M 82.50M 84.89M 87.47M 91.20M 90.83M 93.50M 96.59M 100.27M 112.68M 119.44M

Quarterly Income Statements for Accuray

This table shows Accuray's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12 -1.94
Consolidated Net Income / (Loss)		 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12 -1.94
Net Income / (Loss) Continuing Operations		 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12 -1.94
Total Pre-Tax Income 		-8.74 -5.90 3.86 -3.33 3.23 -0.84 2.07 -21 -13 -11 -1.51
Total Operating Income		 -3.96 -4.56 6.82 -2.15 4.71 1.05 4.23 -11 -12 -9.09 5.52
Total Gross Profit		 36 29 38 34 42 32 39 27 24 25 36
Total Revenue		 107 101 134 102 116 113 128 94 102 105 101
Operating Revenue		 107 101 134 102 116 113 128 94 102 105 101
Total Cost of Revenue		 71 72 96 67 74 82 89 67 78 80 65
Operating Cost of Revenue		 71 72 96 67 74 82 89 67 78 80 65
Total Operating Expenses		 40 34 32 37 37 31 35 38 36 34 30
Selling, General & Admin Expense		 13 12 11 13 12 11 12 15 10 11 9.59
Marketing Expense		 11 10 11 12 11 9.11 11 12 8.85 8.44 9.31
Research & Development Expense		 15 11 9.53 12 14 11 11 11 11 8.18 7.56
Total Other Income / (Expense), net		 -4.78 -1.34 -2.96 -1.18 -1.48 -1.89 -2.16 -9.89 -1.63 -2.25 -7.03
Interest Expense		 2.92 2.88 - 2.96 2.88 2.89 2.75 8.05 7.71 8.45 8.70
Interest & Investment Income		 -0.43 1.02 0.81 -0.07 1.60 2.30 0.89 0.44 0.47 0.41 -0.19
Other Income / (Expense), net		 -1.43 0.52 7.86 1.85 -0.20 -1.29 -0.30 -2.28 5.61 5.79 1.86
Income Tax Expense		 0.88 0.44 0.47 0.63 0.70 0.46 0.95 0.47 0.57 0.47 0.43
Basic Earnings per Share		 ($0.10) ($0.06) $0.03 ($0.04) $0.03 ($0.01) - ($0.18) ($0.11) ($0.09) ($0.02)
Weighted Average Basic Shares Outstanding		 97.78M 99.20M 98.27M 100.23M 101.41K 102.83K 102.77M 118.95M 120.97M 124.30M 122.64M
Weighted Average Diluted Shares Outstanding		 97.78M 99.20M 98.27M 113.34M 103.75K 103.01M 112.68M - 120.97M 118.96M 119.44M
Weighted Average Basic & Diluted Shares Outstanding		 99.17M 99.24M 100.27M 113.34M 102.83M 103.01M 112.68M - 118.78M 118.96M 119.44M

Annual Cash Flow Statements for Accuray

This table details how cash moves in and out of Accuray's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 38 -37 8.64 -5.48 22 8.29 -28 1.05 -19 -9.92 -12
Net Cash From Operating Activities		 31 -0.38 18 -30 -1.47 39 -2.40 16 -12 2.86 -6.98
Net Cash From Continuing Operating Activities		 31 -0.38 18 -30 -1.47 39 -2.40 16 -12 2.86 -6.98
Net Income / (Loss) Continuing Operations		 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59 -49
Consolidated Net Income / (Loss)		 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59 -49
Depreciation Expense		 18 18 9.73 10 7.54 6.39 5.51 4.53 5.91 6.15 7.94
Amortization Expense		 2.53 3.85 1.61 1.53 1.35 1.36 0.82 0.93 0.96 1.44 8.09
Non-Cash Adjustments To Reconcile Net Income		 23 15 27 19 9.50 29 17 14 11 16 15
Changes in Operating Assets and Liabilities, net		 13 -7.60 3.89 -44 -24 8.35 -20 5.40 -14 -19 12
Net Cash From Investing Activities		 8.26 18 18 -4.31 -3.73 -2.40 -4.72 -13 -3.60 -8.52 -12
Net Cash From Continuing Investing Activities		 8.26 18 18 -4.31 -3.73 -2.40 -4.72 -13 -3.60 -8.52 -12
Purchase of Property, Plant & Equipment		 -8.07 -5.03 -6.28 -4.31 -3.56 -2.32 -4.72 -13 -3.60 -4.27 -5.86
Other Investing Activities, net		 - - - - - - - - 0.00 -4.25 -6.42
Net Cash From Financing Activities		 -0.76 -55 -27 28 27 -29 -15 -2.11 -3.95 -4.25 6.98
Net Cash From Continuing Financing Activities		 -0.76 -55 -27 28 27 -29 -15 -2.11 -3.95 -4.25 6.98
Repayment of Debt		 -66 -105 -98 0.00 -0.26 -122 -15 -3.11 -11 -183 -35
Issuance of Debt		 65 48 66 25 25 105 0.00 5.00 5.00 177 37
Issuance of Common Equity		 3.85 3.79 4.39 3.93 2.45 3.03 3.89 2.20 2.25 1.63 0.67
Other Financing Activities, net		 -2.83 -1.42 -0.29 0.00 -0.21 -0.34 -4.26 -6.20 -0.12 -0.09 3.80
Cash Interest Paid		 10 9.93 9.19 9.76 12 12 7.46 9.85 11 9.74 14
Cash Income Taxes Paid		 1.03 4.46 1.46 2.19 2.81 1.87 1.40 2.15 1.75 3.87 2.32

Quarterly Cash Flow Statements for Accuray

This table details how cash moves in and out of Accuray's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -4.20 -12 8.24 -11 6.00 14 -20 7.88 -22 -3.71 5.41
Net Cash From Operating Activities		 -5.09 -8.10 9.88 -7.29 1.80 18 -9.71 12 -16 -5.60 2.43
Net Cash From Continuing Operating Activities		 -5.09 -8.10 9.88 -7.29 1.80 18 -9.71 12 -16 -5.56 2.38
Net Income / (Loss) Continuing Operations		 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12 -1.94
Consolidated Net Income / (Loss)		 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12 -1.94
Depreciation Expense		 1.55 1.60 1.51 1.46 1.51 1.58 1.60 1.68 2.16 2.08 2.03
Amortization Expense		 0.24 0.24 0.24 0.25 0.28 0.27 0.64 1.91 1.62 2.33 2.24
Non-Cash Adjustments To Reconcile Net Income		 1.90 5.24 5.63 7.33 -3.36 6.58 2.54 9.30 -1.54 1.85 5.05
Changes in Operating Assets and Liabilities, net		 0.85 -8.83 -0.89 -12 0.84 11 -16 21 -4.46 -0.01 -4.99
Net Cash From Investing Activities		 -1.25 -0.80 -0.47 -1.12 -1.57 -2.43 -3.40 -3.82 -5.60 -1.51 -1.35
Net Cash From Continuing Investing Activities		 -1.25 -0.80 -0.47 -1.12 -1.57 -2.43 -3.40 -3.82 -5.60 -1.51 -1.35
Purchase of Property, Plant & Equipment		 -1.25 -0.80 -0.47 -1.12 -0.87 -0.96 -1.32 -1.90 -3.03 -0.47 -0.46
Other Investing Activities, net		 - - - 0.00 -0.70 -1.47 -2.08 -1.92 -2.57 -1.04 -0.89
Net Cash From Financing Activities		 -0.26 -1.50 -0.69 -2.17 5.77 -2.00 -5.85 -0.48 -0.28 4.11 3.62
Net Cash From Continuing Financing Activities		 -0.26 -1.50 -0.69 -2.17 5.77 -2.00 -5.85 -0.48 -0.28 4.11 3.62
Repayment of Debt		 - - -5.08 -10 -10 - -163 -2.00 -5.38 -0.51 -27
Issuance of Debt		 - - 5.00 10 17 - 150 2.00 5.00 5.00 25
Issuance of Common Equity		 - - 0.89 - - - 0.77 - - - 0.15
Other Financing Activities, net		 -1.62 -1.50 -1.50 -2.00 -2.09 -2.00 6.00 -0.48 -0.42 -0.38 5.08

Annual Balance Sheets for Accuray

This table presents Accuray's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 469 406 379 438 491 480 473 479 469 470 444
Total Current Assets		 362 309 284 344 357 353 351 338 323 317 288
Cash & Equivalents		 120 72 83 77 108 116 89 89 69 57 41
Restricted Cash		 0.89 13 9.83 10 1.00 0.56 0.20 0.52 0.49 0.57 0.61
Accounts Receivable		 57 73 66 112 91 85 94 75 92 83 67
Inventories, net		 116 105 109 121 134 126 142 145 138 141 147
Prepaid Expenses		 16 19 16 24 21 22 24 28 23 34 32
Other Current Assets		 4.88 3.35 1.14 0.15 2.71 3.01 1.46 0.57 0.85 1.76 0.28
Plant, Property, & Equipment, net		 28 23 24 17 15 12 13 21 25 29 27
Total Noncurrent Assets		 79 74 71 77 118 115 109 120 121 124 129
Long-Term Investments		 - - - 0.00 14 16 14 15 9.83 4.61 5.02
Goodwill		 58 58 58 58 58 58 58 58 58 58 58
Other Noncurrent Operating Assets		 13 15 12 17 44 39 36 46 53 62 66
Total Liabilities & Shareholders' Equity		 469 406 379 438 491 480 473 479 469 470 444
Total Liabilities		 409 360 330 388 427 411 420 426 424 389 402
Total Current Liabilities		 210 284 169 192 182 192 209 199 195 193 191
Short-Term Debt		 40 113 - - 0.00 3.79 8.56 5.72 7.76 13 1.50
Accounts Payable		 15 17 20 30 23 19 31 34 50 34 41
Accrued Expenses		 22 24 22 33 27 27 30 38 29 29 32
Current Deferred Revenue		 114 105 98 99 106 107 101 93 72 82 93
Current Employee Benefit Liabilities		 19 25 29 31 18 27 29 24 17 15 16
Other Current Liabilities		 - - - 0.00 8.22 8.17 8.57 4.15 20 20 8.24
Total Noncurrent Liabilities		 199 75 161 196 245 219 211 227 228 196 211
Long-Term Debt		 171 52 131 160 189 170 172 172 164 124 146
Noncurrent Deferred Revenue		 18 14 21 27 24 24 25 27 24 27 29
Other Noncurrent Operating Liabilities		 11 10 8.61 9.65 32 25 14 28 40 46 36
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 60 47 49 50 64 69 53 54 45 81 42
Total Preferred & Common Equity		 60 47 49 50 64 69 53 54 45 81 42
Total Common Equity		 60 47 49 50 64 69 53 54 45 81 42
Common Stock		 481 497 522 535 546 555 543 555 567 602 614
Retained Earnings		 -421 -450 -474 -486 -482 -488 -493 -502 -518 -519 -568
Accumulated Other Comprehensive Income / (Loss)		 -0.96 -0.05 1.09 -0.01 -0.48 2.09 2.41 0.42 -4.22 -1.84 -3.51

Quarterly Balance Sheets for Accuray

This table presents Accuray's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 477 476 463 473 478 484 457 448 448
Total Current Assets		 334 331 314 330 326 333 304 292 293
Cash & Equivalents		 77 73 60 59 63 78 63 41 38
Restricted Cash		 0.52 0.49 0.67 0.49 1.43 1.01 0.57 0.58 0.47
Accounts Receivable		 77 77 73 92 87 78 54 61 65
Inventories, net		 150 155 160 155 149 146 156 151 157
Prepaid Expenses		 29 25 19 21 25 29 29 37 33
Other Current Assets		 0.56 0.28 1.02 1.72 0.33 0.78 0.43 1.63 0.02
Plant, Property, & Equipment, net		 25 26 25 25 27 27 29 29 29
Total Noncurrent Assets		 118 119 123 118 126 124 124 126 125
Long-Term Investments		 13 15 14 6.05 13 9.28 4.01 5.80 6.32
Goodwill		 58 58 58 58 58 58 58 58 58
Other Noncurrent Operating Assets		 46 46 51 53 54 55 62 63 61
Total Liabilities & Shareholders' Equity		 477 476 463 473 478 484 457 448 448
Total Liabilities		 426 429 421 428 430 435 395 395 406
Total Current Liabilities		 201 209 198 202 201 203 195 199 206
Short-Term Debt		 6.23 6.74 7.25 7.77 7.56 7.57 13 11 11
Accounts Payable		 35 39 44 50 54 46 42 44 53
Accrued Expenses		 37 36 31 25 28 35 26 31 26
Current Deferred Revenue		 91 100 89 94 85 94 92 79 90
Current Employee Benefit Liabilities		 26 21 22 18 19 13 14 15 17
Other Current Liabilities		 6.08 5.71 5.28 6.78 7.52 7.23 7.46 20 8.23
Total Noncurrent Liabilities		 224 219 223 226 229 231 200 195 200
Long-Term Debt		 170 168 166 162 168 166 127 125 134
Noncurrent Deferred Revenue		 27 25 24 24 25 26 26 28 27
Other Noncurrent Operating Liabilities		 28 27 33 39 36 39 47 43 39
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 51 48 41 45 48 50 62 53 42
Total Preferred & Common Equity		 51 48 41 45 48 50 62 53 42
Total Common Equity		 51 48 41 45 48 50 62 53 42
Common Stock		 558 561 564 569 572 575 605 610 611
Retained Earnings		 -505 -515 -521 -522 -519 -520 -541 -555 -567
Accumulated Other Comprehensive Income / (Loss)		 -1.72 1.06 -1.91 -2.48 -5.40 -5.16 -1.98 -1.39 -2.67

Annual Metrics And Ratios for Accuray

This table displays calculated financial ratios and metrics derived from Accuray's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 80,924,480.00 83,000,966.00 85,638,116.00 88,024,096.00 90,516,626.00 93,260,654.00 92,802,213.00 95,751,773.00 - 103,013,384.00 118,963,696.00
DEI Adjusted Shares Outstanding		 80,924,480.00 83,000,966.00 85,638,116.00 88,024,096.00 90,516,626.00 93,260,654.00 92,802,213.00 95,751,773.00 - 103,013,384.00 118,963,696.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.32 -0.36 3.50 -0.19 0.04 -0.07 -0.06 -0.10 - -0.02 -0.41
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.00% -3.86% 111.21% -48.29% -8.56% 3.49% 8.48% 4.12% -0.24% 2.68% -12.34%
EBITDA Growth		 85.15% -183.65% -75.67% 80.09% 733.46% -84.29% 427.92% -44.95% -28.24% 220.93% -96.36%
EBIT Growth		 38.69% -23.19% 19.34% 37.69% 140.71% -193.01% 208.38% -78.39% -259.91% 488.35% -295.81%
NOPAT Growth		 74.58% -101.58% 61.35% 115.35% 1,966.53% 84.56% -63.36% -70.77% -78.84% -3,217.38% -68.30%
Net Income Growth		 36.57% -15.98% 19.20% 31.25% 123.29% -264.91% 15.27% -73.56% -67.51% 89.77% -2,992.02%
EPS Growth		 37.25% -12.50% 22.22% 32.14% 121.05% -275.00% 14.29% -66.67% -60.00% 0.00% 0.00%
Operating Cash Flow Growth		 314.62% -101.23% 4,923.95% -261.70% 95.04% 2,721.65% -106.23% 747.46% -176.61% 124.03% -344.09%
Free Cash Flow Firm Growth		 215.81% -134.28% 261.33% -366.29% 102.48% 4,064.02% -142.64% 143.33% -280.46% -107.00% 75.71%
Invested Capital Growth		 -21.23% 1.25% -15.48% 41.03% 6.22% -15.96% 19.47% -3.87% 9.96% 12.09% -7.59%
Revenue Q/Q Growth		 -1.67% 4.67% 100.84% -54.60% -22.08% 106.48% 2.39% -0.60% 3.72% 0.00% -6.21%
EBITDA Q/Q Growth		 -310.33% 37.06% -5.37% 55.33% -8.99% -83.32% 225.01% 96.12% 134.84% 0.00% 111.46%
EBIT Q/Q Growth		 -7.61% 7.37% 13.20% 5.41% 21.09% -197.10% 135.94% 158.32% 89.98% 0.00% 18.23%
NOPAT Q/Q Growth		 -43.70% 37.02% 6.82% 39.47% 56.05% -9.99% 44.24% -74.87% 107.44% 0.00% 4.65%
Net Income Q/Q Growth		 -6.72% 6.19% 15.28% -2.84% 48.39% -236.34% 69.28% -61.25% 27.66% 0.00% -6.64%
EPS Q/Q Growth		 -10.34% 5.26% 17.65% -5.56% 100.00% -240.00% 68.42% -66.67% 27.27% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 232.96% 89.70% 34.95% -173.42% 86.89% -24.69% -128.44% 671.55% 7.76% -87.26% 63.48%
Free Cash Flow Firm Q/Q Growth		 1,514.15% -16.87% 45.45% -54.24% 109.38% -22.49% -749.34% 257.95% 9.96% 0.00% 75.61%
Invested Capital Q/Q Growth		 -16.87% -12.99% -18.16% -5.24% -9.67% -4.44% 8.64% -4.28% -1.31% 0.00% 0.90%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 39.80% 36.86% 39.93% 38.84% 39.10% 40.25% 37.21% 34.40% 32.01% 32.05% 27.73%
EBITDA Margin		 -0.59% -1.73% -1.44% -0.56% 3.85% 0.58% 2.84% 1.50% 1.08% 3.38% 0.14%
Operating Margin		 -1.22% -2.56% -0.47% 0.14% 3.27% 5.61% 1.90% 0.53% 0.11% 1.71% -6.58%
EBIT Margin		 -5.81% -7.44% -2.84% -3.43% 1.52% -1.37% 1.37% 0.28% -0.46% 1.72% -3.85%
Profit (Net Income) Margin		 -6.40% -7.71% -2.95% -3.92% 1.00% -1.59% -1.24% -2.07% -3.48% -0.35% -12.24%
Tax Burden Percent		 110.08% 103.64% 103.81% 114.54% 67.26% 138.43% 267.08% 136.71% 131.51% -140.30% 104.12%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 97.45% 83.94% -34.01% -533.65% 581.12% 14.36% 305.48%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 32.74% 0.00% 0.00% 0.00% 0.00% 240.30% 0.00%
Return on Invested Capital (ROIC)		 -2.99% -6.79% -2.83% 0.39% 6.73% 13.10% 4.79% 1.31% 0.27% -7.50% -12.41%
ROIC Less NNEP Spread (ROIC-NNEP)		 -50.44% -53.85% -48.52% -30.44% 0.01% -28.52% -14.25% -13.54% -19.25% 3.76% -47.37%
Return on Net Nonoperating Assets (RNNOA)		 -34.68% -48.92% -47.40% -33.75% 0.01% -22.63% -13.55% -18.68% -31.76% 4.98% -67.67%
Return on Equity (ROE)		 -37.66% -55.71% -50.23% -33.36% 6.74% -9.53% -8.76% -17.37% -31.49% -2.52% -80.08%
Cash Return on Invested Capital (CROIC)		 20.77% -8.03% 13.95% -33.66% 0.69% 30.44% -12.95% 5.26% -9.22% -18.90% -4.51%
Operating Return on Assets (OROA)		 -4.95% -6.52% -5.86% -3.51% 1.26% -1.12% 1.24% 0.27% -0.43% 1.68% -3.38%
Return on Assets (ROA)		 -5.45% -6.76% -6.09% -4.02% 0.82% -1.30% -1.12% -1.95% -3.28% -0.34% -10.77%
Return on Common Equity (ROCE)		 -37.66% -55.71% -50.23% -33.36% 6.74% -9.53% -8.76% -17.37% -31.49% -2.52% -80.08%
Return on Equity Simple (ROE_SIMPLE)		 -42.75% -63.57% -49.14% -32.95% 6.01% -9.17% -10.05% -17.29% -34.48% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -3.41 -6.88 -2.66 0.41 8.43 16 5.70 1.67 0.35 -11 -19
NOPAT Margin		 -0.86% -1.79% -0.33% 0.10% 2.20% 3.93% 1.33% 0.37% 0.08% -2.40% -4.60%
Net Nonoperating Expense Percent (NNEP)		 47.46% 47.07% 45.69% 30.84% 6.72% 41.62% 19.04% 14.86% 19.52% -11.25% 34.96%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - -5.05% -9.76%
Cost of Revenue to Revenue		 60.20% 63.14% 60.07% 61.16% 60.90% 59.75% 62.79% 65.60% 67.99% 67.95% 72.27%
SG&A Expenses to Revenue		 12.57% 11.41% 5.94% 11.84% 10.48% 10.53% 10.33% 10.78% 11.21% 10.44% 11.29%
R&D to Revenue		 14.21% 13.02% 7.07% 13.49% 13.00% 13.31% 13.43% 12.76% 11.14% 10.46% 9.39%
Operating Expenses to Revenue		 41.02% 39.43% 0.47% 38.70% 35.82% 34.64% 35.31% 33.86% 31.89% 30.34% 34.31%
Earnings before Interest and Taxes (EBIT)		 -23 -29 -23 -14 5.84 -5.43 5.89 1.27 -2.03 7.90 -15
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.34 -6.65 -12 -2.33 15 2.31 12 6.73 4.83 15 0.56
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.04 8.47 7.22 6.83 2.89 6.12 3.42 6.91 4.01 1.74 0.74
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 34.97 40.36 0.00 0.00 0.00 6.04 0.00
Price to Revenue (P/Rev)		 1.05 1.03 0.43 0.81 0.48 1.06 0.42 0.83 0.40 0.31 0.08
Price to Earnings (P/E)		 0.00 0.00 1.17 0.00 48.01 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 85.30% 0.00% 2.08% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.59 4.41 4.52 3.40 1.94 4.26 2.00 3.55 2.00 1.39 0.92
Enterprise Value to Revenue (EV/Rev)		 1.16 1.17 0.48 0.99 0.65 1.17 0.60 0.99 0.61 0.47 0.33
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 17.01 199.86 21.25 65.84 56.76 13.88 234.96
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 42.91 0.00 44.09 348.10 0.00 27.22 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 1,013.19 29.71 29.71 45.51 265.56 776.36 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 14.96 0.00 21.24 0.00 0.00 12.01 0.00 28.50 0.00 75.19 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 19.49 0.00 29.66 0.00 288.48 12.79 0.00 66.27 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.53 3.54 2.70 3.21 2.97 2.52 3.39 3.30 3.82 1.68 3.55
Long-Term Debt to Equity		 2.86 1.11 2.70 3.21 2.97 2.47 3.23 3.20 3.65 1.53 3.51
Financial Leverage		 0.69 0.91 0.98 1.11 1.21 0.79 0.95 1.38 1.65 1.32 1.43
Leverage Ratio		 6.91 8.24 8.25 8.29 8.19 7.33 7.81 8.91 9.60 7.44 7.44
Compound Leverage Factor		 6.91 8.24 8.25 8.29 7.98 6.15 -2.66 -47.55 55.78 1.07 22.72
Debt to Total Capital		 77.91% 77.96% 72.94% 76.22% 74.84% 71.63% 77.24% 76.77% 79.25% 62.71% 78.00%
Short-Term Debt to Total Capital		 14.77% 53.54% 0.00% 0.00% 0.00% 1.56% 3.66% 2.48% 3.57% 5.85% 0.79%
Long-Term Debt to Total Capital		 63.14% 24.42% 72.94% 76.22% 74.84% 70.07% 73.57% 74.29% 75.68% 56.86% 77.21%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 22.09% 22.04% 27.06% 23.78% 25.16% 28.37% 22.76% 23.23% 20.75% 37.29% 22.00%
Debt to EBITDA		 -89.80 -24.76 -11.23 -68.75 12.85 75.11 14.77 26.36 35.67 8.81 262.65
Net Debt to EBITDA		 -18.14 -8.39 -3.27 -31.32 4.54 17.69 6.36 10.74 19.33 4.77 180.48
Long-Term Debt to EBITDA		 -72.78 -7.76 -11.23 -68.75 12.85 73.47 14.07 25.51 34.07 7.99 259.98
Debt to NOPAT		 -61.68 -23.93 -49.32 391.68 22.45 11.17 31.64 106.32 487.97 -12.41 -7.99
Net Debt to NOPAT		 -12.46 -8.11 -14.36 178.46 7.92 2.63 13.61 43.32 264.38 -6.72 -5.49
Long-Term Debt to NOPAT		 -49.99 -7.50 -49.32 391.68 22.45 10.92 30.14 102.89 465.99 -11.26 -7.91
Altman Z-Score		 0.43 -0.11 1.19 0.24 0.13 0.38 0.11 0.35 -0.02 0.02 -0.70
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.72 1.09 1.68 1.79 1.96 1.83 1.68 1.70 1.66 1.65 1.50
Quick Ratio		 1.06 0.59 0.88 0.98 1.09 1.05 0.88 0.83 0.82 0.73 0.56
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 24 -8.14 13 -35 0.87 36 -15 6.68 -12 -28 -6.73
Operating Cash Flow to CapEx		 383.40% -7.55% 292.08% -687.57% -41.29% 1,660.00% -50.88% 123.19% -330.57% 66.95% -119.11%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -1.90 0.63 -1.04 -2.42 -0.20
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -0.30 1.46 -1.02 0.25 -0.21
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 -0.88 0.28 -1.33 -0.12 -0.39
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.85 0.88 2.06 1.03 0.82 0.82 0.90 0.94 0.94 0.98 0.88
Accounts Receivable Turnover		 5.93 5.92 11.67 4.71 3.78 4.50 4.78 5.29 5.36 5.23 5.34
Inventory Turnover		 2.16 2.19 4.55 2.23 1.83 1.82 2.01 2.04 2.14 2.23 2.02
Fixed Asset Turnover		 13.36 15.05 34.64 20.52 23.59 28.63 34.37 26.63 19.54 17.16 14.36
Accounts Payable Turnover		 16.95 14.80 26.16 10.40 8.85 11.12 10.63 9.02 7.25 7.41 7.79
Days Sales Outstanding (DSO)		 61.57 61.69 31.28 77.52 96.50 81.03 76.33 68.99 68.16 69.73 68.38
Days Inventory Outstanding (DIO)		 168.86 166.64 80.14 163.43 199.71 200.63 181.30 178.62 170.39 163.64 180.99
Days Payable Outstanding (DPO)		 21.53 24.66 13.95 35.10 41.23 32.83 34.35 40.44 50.34 49.24 46.86
Cash Conversion Cycle (CCC)		 208.89 203.67 97.47 205.85 254.98 248.83 223.28 207.17 188.20 184.13 202.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 101 102 86 122 129 109 130 125 137 155 143
Invested Capital Turnover		 3.49 3.78 8.61 4.03 3.06 3.34 3.61 3.52 3.41 3.13 2.69
Increase / (Decrease) in Invested Capital		 -27 1.26 -16 35 7.57 -21 21 -5.01 12 17 -12
Enterprise Value (EV)		 463 450 389 413 251 462 260 443 274 215 132
Market Capitalization		 420 394 351 341 184 422 182 371 181 141 31
Book Value per Share		 $0.74 $0.56 $0.57 $0.57 $0.70 $0.74 $0.57 $0.56 $0.45 $0.79 $0.35
Tangible Book Value per Share		 ($0.07) ($0.15) ($0.12) ($0.10) $0.06 $0.11 ($0.05) ($0.04) ($0.13) $0.23 ($0.14)
Total Capital		 270 211 180 210 253 243 234 231 217 218 190
Total Debt		 210 165 131 160 189 174 180 177 172 137 148
Total Long-Term Debt		 171 52 131 160 189 170 172 172 164 124 146
Net Debt		 43 56 38 73 67 41 78 72 93 74 102
Capital Expenditures (CapEx)		 8.07 5.03 6.28 4.31 3.56 2.32 4.72 13 3.60 4.27 5.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 23 29 22 65 67 47 62 55 67 80 57
Debt-free Net Working Capital (DFNWC)		 191 138 115 152 175 164 151 145 136 138 98
Net Working Capital (NWC)		 151 25 115 152 175 160 142 139 128 125 96
Net Nonoperating Expense (NNE)		 22 23 21 17 4.61 22 11 11 16 -9.41 31
Net Nonoperating Obligations (NNO)		 41 55 38 72 65 40 76 71 92 74 102
Total Depreciation and Amortization (D&A)		 21 22 11 12 8.89 7.75 6.33 5.45 6.86 7.59 16
Debt-free, Cash-free Net Working Capital to Revenue		 5.88% 7.49% 2.69% 15.49% 17.40% 11.93% 14.34% 12.33% 14.93% 17.37% 14.09%
Debt-free Net Working Capital to Revenue		 47.99% 35.87% 14.17% 36.27% 45.76% 41.44% 35.03% 32.42% 30.39% 30.01% 24.35%
Net Working Capital to Revenue		 37.98% 6.39% 14.17% 36.27% 45.76% 40.48% 33.04% 31.14% 28.66% 27.24% 23.98%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) ($0.02) ($0.40)
Adjusted Weighted Average Basic Shares Outstanding		 81.57M 83.75M 86.49M 88.78M 89.87M 92.03M 92.10M 94.88M 98.27M 102.77M 122.64M
Adjusted Diluted Earnings per Share		 ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 81.57M 83.75M 86.49M 88.78M 90.62M 92.03M 92.10M 94.88M 98.27M 112.68M 119.44M
Adjusted Basic & Diluted Earnings per Share		 ($0.32) ($0.36) ($0.28) ($0.19) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 80.51M 82.50M 84.89M 87.47M 91.20M 90.83M 93.50M 96.59M 100.27M 112.68M 119.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -3.41 -6.88 -2.66 0.41 8.43 16 5.70 1.67 0.35 5.49 -7.19
Normalized NOPAT Margin		 -0.86% -1.79% -0.33% 0.10% 2.20% 3.93% 1.33% 0.37% 0.08% 1.20% -1.79%
Pre Tax Income Margin		 -5.81% -7.44% -2.84% -3.43% 1.49% -1.15% -0.47% -1.52% -2.65% 0.25% -11.75%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.72 0.12 -0.18 0.69 -0.47
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.70 0.16 0.03 -0.96 -0.56
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.14 -1.07 -0.48 0.32 -0.65
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.12 -1.03 -0.28 -1.33 -0.74
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -223.10% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Accuray

This table displays calculated financial ratios and metrics derived from Accuray's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 97,072,183.00 99,168,765.00 - 100,267,900.00 - 102,830,522.00 103,013,384.00 112,677,147.00 113,341,132.00 356,347,890.00 118,963,696.00
DEI Adjusted Shares Outstanding		 97,072,183.00 99,168,765.00 - 100,267,900.00 - 102,830,522.00 103,013,384.00 112,677,147.00 113,341,132.00 356,347,890.00 118,963,696.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.10 -0.06 - -0.04 - -0.01 0.01 -0.19 -0.12 -0.03 -0.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -6.55% -14.34% 13.52% 0.00% 8.33% 11.98% -6.65% -7.49% -11.99% -7.42% -20.87%
EBITDA Growth		 -388.19% -602.51% 96.00% 0.00% 224.92% 172.60% -34.66% -807.13% -134.56% -30.91% 88.65%
EBIT Growth		 -4,180.95% -345.70% 108.29% 0.00% 183.63% 93.88% -48.87% -4,401.32% -232.10% -1,235.63% 87.58%
NOPAT Growth		 -246.54% -358.04% 1,970.82% 0.00% 233.16% 122.95% -71.11% -426.43% -319.12% -967.91% 68.42%
Net Income Growth		 -413.39% -1,158.76% 232.51% 0.00% 126.37% 79.55% -74.31% -448.25% -642.77% -810.18% -272.84%
EPS Growth		 -400.00% -700.00% 200.00% 0.00% 120.00% 0.00% 0.00% 0.00% -650.00% 0.00% 0.00%
Operating Cash Flow Growth		 71.73% -132.90% 11.27% 0.00% 0.00% 322.92% -198.24% 266.99% -987.62% -131.02% 125.00%
Free Cash Flow Firm Growth		 125.51% -23.02% -236.88% 112.47% -158.26% 148.37% -148.83% -174.56% 43.83% -354.02% 208.39%
Invested Capital Growth		 -11.11% 6.65% 9.96% -13.61% 8.84% -3.60% 12.09% 4.69% -2.44% 6.12% -7.59%
Revenue Q/Q Growth		 5.61% -5.69% 32.79% -25.68% 0.00% -2.52% 12.63% 0.00% 8.83% 2.55% -3.74%
EBITDA Q/Q Growth		 -355.01% 39.05% 422.97% -85.02% 0.00% -74.63% 286.42% 0.00% 78.26% 150.71% 955.16%
EBIT Q/Q Growth		 -1,686.09% 25.14% 311.96% -103.92% 0.00% -105.48% 1,693.93% 0.00% 56.16% 44.64% 323.86%
NOPAT Q/Q Growth		 -84.46% -15.09% 287.41% -118.93% 0.00% -80.16% 213.26% 0.00% -2.24% 21.43% 160.79%
Net Income Q/Q Growth		 -143.32% 34.08% 153.41% -190.44% 0.00% -151.12% 186.58% 0.00% 36.48% 14.27% 83.56%
EPS Q/Q Growth		 -150.00% 40.00% 150.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 30.18% -59.08% 221.97% -173.81% 0.00% 902.83% -153.75% 225.46% -231.25% 64.96% 143.32%
Free Cash Flow Firm Q/Q Growth		 109.28% -185.19% 45.76% 518.64% 0.00% 170.73% -351.87% 0.00% 67.34% -219.87% 207.47%
Invested Capital Q/Q Growth		 -10.05% 4.09% -1.31% -6.51% 0.00% -7.81% 15.88% 0.00% 5.61% 0.28% 0.90%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.48% 28.75% 28.63% 33.94% 36.06% 27.93% 30.56% 28.26% 23.54% 24.13% 35.22%
EBITDA Margin		 -3.37% -2.18% 12.23% 1.39% 3.88% 1.41% 4.84% -10.66% -2.13% 1.05% 11.54%
Operating Margin		 -3.70% -4.51% 5.08% -2.12% 4.05% 0.92% 3.32% -12.04% -11.31% -8.67% 5.47%
EBIT Margin		 -5.03% -3.99% 10.93% -0.30% 3.88% -0.22% 3.09% -14.47% -5.83% -3.15% 7.32%
Profit (Net Income) Margin		 -8.97% -6.27% 2.52% -3.89% 2.18% -1.15% 0.88% -23.08% -13.47% -11.26% -1.92%
Tax Burden Percent		 110.04% 107.53% 87.79% 118.77% 78.50% 154.40% 54.23% 102.22% 104.34% 104.13% 128.80%
Interest Burden Percent		 162.09% 146.06% 26.30% 1,102.32% 71.65% 340.08% 52.60% 156.00% 221.46% 343.65% -20.41%
Effective Tax Rate		 0.00% 0.00% 12.21% 0.00% 21.50% 0.00% 45.78% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -8.17% -10.11% 15.21% -4.79% 0.00% 2.22% 5.63% -28.99% -24.13% -18.85% 10.32%
ROIC Less NNEP Spread (ROIC-NNEP)		 -15.61% -13.74% 12.02% -7.68% 0.00% -0.01% 4.22% -48.86% -30.25% -24.75% 3.71%
Return on Net Nonoperating Assets (RNNOA)		 -28.90% -24.85% 19.83% -12.14% 0.00% -0.02% 5.59% -54.69% -55.38% -50.04% 5.29%
Return on Equity (ROE)		 -37.07% -34.96% 35.05% -16.93% 0.00% 2.20% 11.22% -83.68% -79.51% -68.89% 15.62%
Cash Return on Invested Capital (CROIC)		 11.82% -9.96% -9.22% 14.86% 0.00% 7.11% -18.90% -5.29% -6.12% -20.01% -4.51%
Operating Return on Assets (OROA)		 -4.76% -3.66% 10.29% -0.29% 0.00% -0.22% 3.01% -14.28% -5.50% -2.89% 6.44%
Return on Assets (ROA)		 -8.50% -5.76% 2.38% -3.74% 0.00% -1.13% 0.86% -22.78% -12.71% -10.36% -1.69%
Return on Common Equity (ROCE)		 -37.07% -34.96% 35.05% -16.93% 0.00% 2.20% 11.22% -83.68% -79.51% -68.89% 15.62%
Return on Equity Simple (ROE_SIMPLE)		 -30.53% -52.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.77 -3.19 5.98 -1.50 3.69 0.73 2.30 -7.92 -8.10 -6.36 3.87
NOPAT Margin		 -2.59% -3.16% 4.46% -1.48% 3.18% 0.65% 1.80% -8.43% -7.92% -6.07% 3.83%
Net Nonoperating Expense Percent (NNEP)		 7.44% 3.64% 3.19% 2.89% 1.27% 2.23% 1.40% 19.87% 6.12% 5.90% 6.62%
Return On Investment Capital (ROIC_SIMPLE)		 -1.25% -1.49% - -0.74% 1.65% 0.33% 1.05% -3.92% -4.28% -3.40% 2.04%
Cost of Revenue to Revenue		 66.52% 71.25% 71.37% 66.06% 63.94% 72.07% 69.44% 71.74% 76.46% 75.87% 64.78%
SG&A Expenses to Revenue		 12.33% 12.27% 8.50% 12.62% 10.70% 9.50% 9.30% 15.46% 9.84% 10.71% 9.50%
R&D to Revenue		 14.25% 10.79% 7.10% 11.93% 11.74% 9.46% 8.99% 12.10% 10.42% 7.80% 7.49%
Operating Expenses to Revenue		 37.18% 33.26% 23.56% 36.06% 32.01% 27.00% 27.24% 40.30% 34.86% 32.79% 29.74%
Earnings before Interest and Taxes (EBIT)		 -5.39 -4.04 15 -0.30 4.51 -0.25 3.94 -14 -5.96 -3.30 7.39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -3.61 -2.20 16 1.42 4.51 1.60 6.18 -10 -2.18 1.10 12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.76 5.96 4.01 2.92 4.16 3.71 1.74 3.04 1.75 1.11 0.74
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 44.60 0.00 0.00 6.04 46.50 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.61 0.57 0.40 0.40 0.00 0.39 0.31 0.42 0.21 0.11 0.08
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 111.02 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.90% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 2.71 2.48 2.00 1.97 2.05 2.02 1.39 1.94 1.28 1.03 0.92
Enterprise Value to Revenue (EV/Rev)		 0.81 0.80 0.61 0.57 0.00 0.58 0.47 0.58 0.42 0.34 0.33
Enterprise Value to EBITDA (EV/EBITDA)		 44.39 62.38 56.76 52.37 0.00 14.37 13.88 64.16 0.00 0.00 234.96
Enterprise Value to EBIT (EV/EBIT)		 164.56 0.00 0.00 0.00 0.00 23.13 27.22 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 4,784.33 0.00 776.36 716.34 0.00 57.36 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.25 0.00 0.00 0.00 0.00 12.01 75.19 11.66 39.95 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 21.59 0.00 0.00 12.30 0.00 27.81 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.67 4.22 3.82 2.27 3.66 3.50 1.68 2.27 2.54 3.48 3.55
Long-Term Debt to Equity		 3.53 4.05 3.65 2.06 3.51 3.35 1.53 2.06 2.34 3.21 3.51
Financial Leverage		 1.85 1.81 1.65 1.58 1.92 2.01 1.32 1.12 1.83 2.02 1.43
Leverage Ratio		 9.51 9.80 9.60 8.68 9.99 10.44 7.44 7.38 9.14 10.21 7.44
Compound Leverage Factor		 15.41 14.31 2.52 95.72 7.16 35.52 3.91 11.52 20.25 35.08 -1.52
Debt to Total Capital		 78.57% 80.85% 79.25% 69.38% 78.56% 77.80% 62.71% 69.38% 71.78% 77.68% 78.00%
Short-Term Debt to Total Capital		 3.03% 3.38% 3.57% 6.36% 3.38% 3.39% 5.85% 6.36% 5.87% 5.97% 0.79%
Long-Term Debt to Total Capital		 75.54% 77.48% 75.68% 63.02% 75.18% 74.41% 56.86% 63.02% 65.91% 71.71% 77.21%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 21.43% 19.15% 20.75% 30.62% 21.44% 22.20% 37.29% 30.62% 28.22% 22.32% 22.00%
Debt to EBITDA		 21.45 31.49 35.67 29.04 0.00 9.26 8.81 34.53 -30.76 -29.56 262.65
Net Debt to EBITDA		 10.67 17.93 19.33 14.97 0.00 4.57 4.77 17.80 -19.97 -20.43 180.48
Long-Term Debt to EBITDA		 20.62 30.17 34.07 26.38 0.00 8.86 7.99 31.37 -28.25 -27.29 259.98
Debt to NOPAT		 2,311.61 -36.61 487.97 397.30 0.00 36.96 -12.41 -151.13 -11.03 -7.48 -7.99
Net Debt to NOPAT		 1,150.54 -20.84 264.38 204.77 0.00 18.22 -6.72 -77.89 -7.16 -5.17 -5.49
Long-Term Debt to NOPAT		 2,222.49 -35.08 465.99 360.87 0.00 35.35 -11.26 -137.27 -10.13 -6.90 -7.91
Altman Z-Score		 0.08 -0.03 0.09 -0.12 0.00 0.04 -0.01 -0.20 -0.41 -0.54 -0.53
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.58 1.58 1.66 1.56 1.62 1.64 1.65 1.56 1.47 1.42 1.50
Quick Ratio		 0.72 0.67 0.82 0.60 0.74 0.77 0.73 0.60 0.51 0.50 0.56
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 14 -12 -6.43 19 -8.10 5.73 -14 -14 -4.55 -15 16
Operating Cash Flow to CapEx		 -407.77% -1,019.12% 2,125.16% -651.25% 0.00% 1,885.28% -735.45% 639.71% -528.46% -1,189.38% 526.46%
Free Cash Flow to Firm to Interest Expense		 4.76 -4.11 0.00 6.32 -2.81 1.98 -5.25 -1.73 -0.59 -1.72 1.80
Operating Cash Flow to Interest Expense		 -1.74 -2.81 0.00 -2.47 0.00 6.25 -3.53 1.51 -2.07 -0.66 0.28
Operating Cash Flow Less CapEx to Interest Expense		 -2.17 -3.09 0.00 -2.85 0.00 5.92 -4.01 1.28 -2.47 -0.72 0.23
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.95 0.92 0.94 0.96 0.00 0.99 0.98 0.99 0.94 0.92 0.88
Accounts Receivable Turnover		 5.37 5.72 5.36 6.11 0.00 6.18 5.23 8.29 5.90 6.00 5.34
Inventory Turnover		 1.90 1.86 2.14 1.96 0.00 2.07 2.23 2.01 2.11 2.07 2.02
Fixed Asset Turnover		 24.14 23.20 19.54 16.43 0.00 17.82 17.16 15.54 15.57 15.28 14.36
Accounts Payable Turnover		 8.10 7.89 7.25 6.59 0.00 6.97 7.41 7.36 6.48 6.33 7.79
Days Sales Outstanding (DSO)		 67.94 63.79 68.16 59.74 0.00 59.07 69.73 44.02 61.91 60.79 68.38
Days Inventory Outstanding (DIO)		 191.88 196.26 170.39 186.56 0.00 176.66 163.64 182.00 173.28 176.33 180.99
Days Payable Outstanding (DPO)		 45.08 46.24 50.34 55.42 0.00 52.39 49.24 49.63 56.36 57.67 46.86
Cash Conversion Cycle (CCC)		 214.74 213.81 188.20 190.87 0.00 183.34 184.13 176.40 178.83 179.45 202.51
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 133 139 137 128 145 134 155 134 142 142 143
Invested Capital Turnover		 3.16 3.20 3.41 3.23 0.00 3.43 3.13 3.44 3.05 3.11 2.69
Increase / (Decrease) in Invested Capital		 -17 8.65 12 -20 12 -5.00 17 6.01 -3.55 8.19 -12
Enterprise Value (EV)		 362 344 274 253 298 270 215 260 182 146 132
Market Capitalization		 275 245 181 180 199 184 141 188 93 46 31
Book Value per Share		 $0.49 $0.41 $0.45 $0.62 $0.48 $0.48 $0.79 $0.55 $0.47 $0.35 $0.35
Tangible Book Value per Share		 ($0.11) ($0.17) ($0.13) $0.04 ($0.10) ($0.08) $0.23 $0.04 ($0.04) ($0.14) ($0.14)
Total Capital		 222 215 217 202 223 223 218 202 189 187 190
Total Debt		 175 173 172 140 176 174 137 140 136 145 148
Total Long-Term Debt		 168 166 164 127 168 166 124 127 125 134 146
Net Debt		 87 99 93 72 99 86 74 72 88 100 102
Capital Expenditures (CapEx)		 1.25 0.80 0.47 1.12 0.00 0.96 1.32 1.90 3.03 0.47 0.46
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 55 62 67 58 68 59 80 58 62 60 57
Debt-free Net Working Capital (DFNWC)		 129 123 136 122 132 138 138 122 104 99 98
Net Working Capital (NWC)		 122 116 128 109 124 130 125 109 93 87 96
Net Nonoperating Expense (NNE)		 6.85 3.15 2.60 2.45 1.16 2.03 1.17 14 5.67 5.44 5.81
Net Nonoperating Obligations (NNO)		 86 98 92 66 97 84 74 72 88 100 102
Total Depreciation and Amortization (D&A)		 1.78 1.84 1.75 1.72 0.00 1.85 2.24 3.58 3.78 4.40 4.26
Debt-free, Cash-free Net Working Capital to Revenue		 12.37% 14.32% 14.93% 12.97% 0.00% 12.57% 17.37% 12.85% 14.23% 14.00% 14.09%
Debt-free Net Working Capital to Revenue		 28.74% 28.51% 30.39% 27.29% 0.00% 29.43% 30.01% 27.02% 23.81% 22.99% 24.35%
Net Working Capital to Revenue		 27.23% 26.83% 28.66% 24.41% 0.00% 27.81% 27.24% 24.17% 21.27% 20.39% 23.98%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.10) ($0.06) $0.03 ($0.18) $0.03 ($0.01) $0.00 ($0.18) ($0.11) ($0.09) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding		 97.78M 99.20M 98.27M 118.95M 101.41M 102.83M 102.77M 118.95M 120.97M 124.30M 122.64M
Adjusted Diluted Earnings per Share		 ($0.10) ($0.06) $0.03 ($0.18) $0.02 ($0.01) $0.00 $0.00 ($0.11) $0.00 $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 97.78M 99.20M 98.27M 118.95M 103.75M 102.83M 112.68M 0.00 120.97M 118.96M 119.44M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 99.17M 99.24M 100.27M 113.34M 102.83M 103.01M 112.68M 0.00 118.78M 118.96M 119.44M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.77 -3.19 5.98 -1.50 3.69 0.73 2.30 -7.92 -3.84 -1.78 3.87
Normalized NOPAT Margin		 -2.59% -3.16% 4.46% -1.48% 3.18% 0.65% 1.80% -8.43% -3.76% -1.70% 3.83%
Pre Tax Income Margin		 -8.15% -5.83% 2.87% -3.28% 2.78% -0.74% 1.62% -22.57% -12.91% -10.81% -1.49%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -1.85 -1.40 0.00 -0.10 1.56 -0.09 1.43 -1.69 -0.77 -0.39 0.85
NOPAT to Interest Expense		 -0.95 -1.11 0.00 -0.51 1.28 0.25 0.83 -0.98 -1.05 -0.75 0.44
EBIT Less CapEx to Interest Expense		 -2.27 -1.68 0.00 -0.48 0.00 -0.42 0.95 -1.92 -1.17 -0.45 0.80
NOPAT Less CapEx to Interest Expense		 -1.38 -1.38 0.00 -0.89 0.00 -0.08 0.35 -1.22 -1.44 -0.81 0.39
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Accuray’s latest quarterly results show meaningful operational improvement, but the company remains unprofitable and financially leveraged. Revenue was $100.9 million in Q4 2026, down from $127.5 million in Q4 2025 and the lowest quarterly level in the latest four-quarter period. However, gross profit increased to $35.5 million from $25.3 million a year earlier, lifting the gross margin to approximately 35.2% from 19.7%.

Cost controls also helped Accuray return to positive operating income. Operating expenses fell to $30.0 million in Q4 2026 from $34.4 million in the prior-year quarter, while operating income improved to $5.5 million from a $9.1 million loss in Q3 2026. The company’s net loss narrowed sharply to $1.9 million, compared with losses of $11.8 million in Q3 2026 and $13.8 million in Q2 2026.

Cash flow improved in the latest quarter, with $2.4 million of operating cash flow following three consecutive quarters of negative operating cash flow. Total cash increased by $5.4 million during Q4 2026, although the increase was supported in part by financing activity rather than operations alone.

The balance sheet remains a key risk. Cash and equivalents declined to $38.1 million as of March 31, 2026, compared with $63.3 million at the end of Q1 2026 and $77.8 million a year earlier. Total liabilities of $405.9 million substantially exceeded shareholders’ equity of $41.7 million. Interest expense also rose to $8.7 million in the latest income statement, limiting the benefit of the company’s improved operating performance.

  • Improved gross margins: Q4 2026 gross margin rose to approximately 35.2%, up from about 19.7% in Q4 2025 and the strongest margin among the latest reported quarters.
  • Return to positive operating income: Accuray generated $5.5 million of operating income in Q4 2026 after reporting operating losses in each of the preceding three quarters.
  • Net losses are narrowing: The quarterly net loss improved from $21.7 million in Q1 2026 to $1.9 million in Q4 2026, indicating progress toward profitability.
  • Operating cash flow turned positive: Operating cash flow improved to $2.4 million in Q4 2026 from negative cash flow of $5.6 million in Q3 and $16.0 million in Q2.
  • Lower operating expenses: Total operating expenses declined to $30.0 million in Q4 2026, below the $34.4 million recorded in Q4 2025 and the $37.9 million reported in Q1 2026.
  • Revenue remains volatile: Quarterly revenue has fluctuated between approximately $93.9 million and $127.5 million over the latest four quarters, making it difficult to establish a consistent growth trend.
  • Inventory remains elevated: Net inventory stood at $156.6 million at the end of Q3 2026, representing more than half of total current assets and potentially tying up working capital.
  • Revenue declined year over year: Q4 2026 revenue fell approximately 20.9% from Q4 2025, despite the improvement in gross margin and operating income.
  • Cash reserves have weakened: Cash and equivalents declined to $38.1 million from $77.8 million a year earlier, reducing the company’s cushion while it continues to report losses.
  • Leverage and interest costs remain significant: Total debt was approximately $145.2 million at the latest balance-sheet date, while Q4 2026 interest expense reached $8.7 million. Liabilities were nearly 10 times reported shareholders’ equity, creating ongoing refinancing and liquidity risk.
09/05/26 08:25 PM ETAI Generated. May Contain Errors.

Accuray Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Accuray's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Over the last 10 years, Accuray's net income changed from -$25.50 million in 2016 to -$49.19 million in 2026, a change of 92.9%. See where experts think Accuray is headed by visiting Accuray's forecast page.

Accuray's total operating income in 2026 was -$26.44 million, based on the following breakdown:
  • Total Gross Profit: $111.45 million
  • Total Operating Expenses: $137.90 million

Over the last 10 years, Accuray's total revenue changed from $398.80 million in 2016 to $401.95 million in 2026, a change of 0.8%.

Accuray's total liabilities were at $401.98 million at the end of 2026, a 3.3% increase from 2025, and a 1.8% decrease since 2016.

In the past 10 years, Accuray's cash and equivalents has ranged from $40.62 million in 2026 to $119.77 million in 2016, and is currently $40.62 million as of their latest financial filing in 2026.

Over the last 10 years, Accuray's book value per share changed from 0.74 in 2016 to 0.35 in 2026, a change of -52.5%.


Related Companies

Financial statements for NASDAQ:ARAY last updated on 8/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel